Priming of circulating human eosinophils following late response to allergen challenge

European Respiratory Journal

Volumn 9, Issue 4, 1996, Pages 703-708

  Evans, D J ^a   Lindsay, M A ^b   O'Connor, B J ^a   Barnes, P J ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; cell survival; eosinophils; nicotinamide adenine dinucleotide phosphate (reduced form) oxidoreductase; priming

Indexed keywords

ALLERGEN; COMPLEMENT COMPONENT C5A; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ARTICLE; ASTHMA; CELL SURVIVAL; CLINICAL ARTICLE; EFFECTOR CELL; EOSINOPHIL; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL;

ADULT; ASTHMA; BRONCHIAL PROVOCATION TESTS; CELL SURVIVAL; COMPLEMENT C5A; EOSINOPHILS; HUMANS; HYDROGEN PEROXIDE; IMMUNIZATION; PLATELET ACTIVATING FACTOR;

EID: 0029937469     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09040703     Document Type: Article

References (25)

1. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunology 1990; 85: 422-436.
2. Ding-E YJ, Peterson CGB, Venge P, Cohn ZA. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986; 321: 613-616.
3. Fredens K, Dahl R, Venge P. Eosinophils and cellular injury: the Gordon phenomenon as a model. N Engl Reg Allergy Proc 1985; 6: 346-351.
4. Lee TC, Lenihan DJ, Malone B, Roddy LL, Wasserman SI. Increased biosynthesis of platelet-activating factor in activated eosinophils. J Biol Chem 1984; 259: 5526-5532.
5. 4 by human eosinophils. Clin Exp Immunol 1984; 70: 716-722.
6. Chanez P, Dent G, Yukawa T, Barnes PJ, Chung KF. Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. Eur Respir J 1990; 3: 1002-1007.
7. Dor PJ, Ackerman SJ, Gleich GJ. Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory disease. Am Rev Respir Dis 1984; 130: 1072-1077.
8. De Monchy JGR, Kauffman HK, Venge P, et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373-376.
9. Sedgwick JB, Calhoun WJ, Vrtis RF, Bates ME, McAllister PK, Busse WW. Comparison of airway and blood eosinophil function after allergen challenge. J Immunol 1992; 149: 3710-3718.
10. Kroegel C, Liu MC, Hubbard WC, Lichtenstein LM, Bochner BS. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production. J Allergy Clin Immunol 1994; 93: 725-734.
11. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late phase reaction. Am Rev Respir Dis 1993; 147: 901-907.
12. Barnes PJ, Chung KF, Page CB. Platelet-activating factor as a mediator of allergic disease. J Allergy Clin Immunol 1988; 147: 919-934.
13. Hansel TT, Pound JD, Pilling D, et al. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 1989; 122: 97-103.
14. 2 release from human granulocytes during phagocytosis. I. Documentation, quantification and some regulating factors. J Clin Invest 1975; 55: 945-955.
15. 2- in response to physiologic soluble stimuli is differentially modulated by extracellular matrix components and endothelial cells. J Immunol 1991; 147: 613-620.
16. Pabst MJ. Priming of neutrophils. In: Hellewell PG, Williams TJ, eds. The Handbook of Immunopharmacology: Immunopharmacology of Neutrophils. London, Academic Press, 1994; pp. 195-221.
17. 2 subfamilies of integrins by antibodies triggers eosinophil respiratory burst and spreading. Immunology 1993; 80: 272-280.
18. Nathan CF. Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80: 1550-1560.
19. Nathan C, Srimal S, Farber C, et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol 1989; 109: 1341-1349.
20. Neeley SP, Hamann KJ, White SR, Baranowski SL, Burch RA, Leff AR. Selective regulation of expression of surface adhesion molecules Mac-1, L-selectin, and VLA-4 on human eosinophils and neutrophils. Am J Respir Cell Mol Biol 1993; 8: 633-639.
21. Koenderman L, Tool ATJ, Roos D, Verhoeven AJ. Priming of the respiratory burst in human eosinophils is accompanied by changes in signal transduction. J Immunol 1990; 145: 3883-3888.
22. Rothenburg ME, Owen WF Jr, Silberstein DS, et al. Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin-3. J Clin Invest 1988; 81: 1986-1992.
23. Rothenberg ME, Petersen J, Stevens RL, et al. IL-5-dependent conversion of normodense human eosinophils to hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol 1989; 143: 2311-2316.
24. Owen WF Jr, Rothenberg ME, Silberstein DS, Gasson JC, Stevens RL, Austen KF. Regulation of human eosinophil viability, density, and function by granulocyte/ macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987; 166: 129-136.
25. Anwar AR, Moqbel R, Walsh GM, Kay AB, Wardlaw AJ. Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 1993; 177: 839-843.